MyAverix Finance
SHE · Healthcare
Hangzhou Tigermed Consulting (300347)
Diagnostics & Research
Hangzhou Tigermed Consulting (300347) is listed on SHE in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300347
Hangzhou Tigermed Consulting (300347) — FAQ
What is 300347's P/E ratio?
The price-to-earnings (P/E) ratio for Hangzhou Tigermed Consulting (300347) is 18.00 (data as of 2026-03-25).
Does Hangzhou Tigermed Consulting pay a dividend?
Dividend yield is not available in the current snapshot for Hangzhou Tigermed Consulting (300347). Check the MyAverix Finance app for the latest dividend data.
What sector is Hangzhou Tigermed Consulting in?
Hangzhou Tigermed Consulting (300347) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 300347 listed on?
300347 is listed on SHE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.